| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142342 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions |
| 07/22/2004 | US20040142332 Desaturase antigen of mycobacterium tuberculosis |
| 07/22/2004 | US20040142086 Method and apparatus for separation of milk, colostrum, and whey |
| 07/22/2004 | US20040142068 Method and apparatus for separation of milk, colostrum, and whey |
| 07/22/2004 | US20040141998 antigen is targeted to the receptor of the antigen-presenting cell, in some instances without being blocked by the natural ligand for the surface receptor; molecular complexes including the binding agent coupled to an antigen. |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141996 deglycosylated HIV proteins comprise at least one epitope region which does not elicit an immune response in man when encountered by infection or environmental exposure but does elicit an immune response in a non-human species. |
| 07/22/2004 | US20040141983 Compositions against cancer antigen LIV-1 and uses thereof |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/22/2004 | US20040141981 administering biological conjugates comprising chlorotoxin sensitive cytoplasmic proteins, used for the screening and prophylaxis of cancer |
| 07/22/2004 | US20040141980 Recombinant antibodies against infectious bursal disease virus (ibdv) |
| 07/22/2004 | US20040141979 isolation and production of cancerous disease modifying antibodies (CDMAB) and to the use of these CDMAB in therapeutic and diagnostic processes; anticancer agents |
| 07/22/2004 | US20040141977 the ATRX gene and/or its polypeptide product are anti-apoptopic, and provide a positive viability signal to the apoptotic pathway; methods for treating, diagnosing, prognosing apoptosis related diseases |
| 07/22/2004 | US20040141975 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 07/22/2004 | US20040141973 IPG antagonists for the treatment of conditions involving mast cells, basophils and eosinophils |
| 07/22/2004 | US20040141972 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/22/2004 | US20040141971 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/22/2004 | US20040141970 recombinant production of novel DNA and novel polypeptides the presence of which is associated with inflammatory diseases (inflammation associated antigens) and/or cancer; diagnosis and treatment of conditions characterized by such antigens |
| 07/22/2004 | US20040141969 Antibody binding to platelet devived growth factor; antiproliferative agents |
| 07/22/2004 | US20040141968 Binding to lecithin receptor; viricides |
| 07/22/2004 | US20040141967 Methods and compositions for treating macrophage-mediated diseases |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141965 Immunohistochemistry; diagnosis of human breast cancer |
| 07/22/2004 | US20040141964 Recombinant IL-18 antagonists useful in treatment of IL-18 mediated disorders |
| 07/22/2004 | US20040141959 Somatic cells with ablated PrP gene and methods of use |
| 07/22/2004 | US20040141958 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | US20040141915 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141914 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141913 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040139864 Method and apparatus for separation of milk, colostrum, and whey |
| 07/22/2004 | DE10300335A1 Oxidoreduktase Oxidoreductase |
| 07/22/2004 | CA2512647A1 Method for manufacturing recombinant polyclonal proteins |
| 07/22/2004 | CA2512138A1 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | CA2511838A1 Uses of mammalian cytokine; related reagents |
| 07/22/2004 | CA2511823A1 Combination therapy with co-stimulatory factors |
| 07/22/2004 | CA2511817A1 Novel compositions and methods in cancer |
| 07/22/2004 | CA2511816A1 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | CA2511513A1 Methods of inducing and maintaining immune tolerance |
| 07/22/2004 | CA2510433A1 Target recognizing binding agents |
| 07/21/2004 | EP1439229A2 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439223A1 Novel class ii cytokine receptor |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439192A1 Neuropilin-1 inhibitors |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1439188A1 Search for cancer marker by novel screening method |
| 07/21/2004 | EP1438970A2 Methods for inhibiting HIV associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells |
| 07/21/2004 | EP1438434A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 07/21/2004 | EP1438431A2 Methods for diagnosing and treating heart disease |
| 07/21/2004 | EP1438425A2 69583 and 85924,novel human protein kinase family members and uses therefor |
| 07/21/2004 | EP1438402A2 Modulators of bone homeostasis identified in a high-throughput screen |
| 07/21/2004 | EP1438401A2 Production of a transgenic avian by cytoplasmic injection |
| 07/21/2004 | EP1438389A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 07/21/2004 | EP1438388A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 07/21/2004 | EP1438386A2 Transmembrane protein differentially expressed in cancer |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438340A2 Antibodies against kdr, their production and uses |
| 07/21/2004 | EP1438339A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 07/21/2004 | EP1438338A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 07/21/2004 | EP1438334A2 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 07/21/2004 | EP1438331A1 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 07/21/2004 | EP1438077A1 Methods of sterilizing biological materials containing non-aqueous solvents |
| 07/21/2004 | EP1438068A2 Antibody inhibitors of gdf-8 and uses thereof |
| 07/21/2004 | EP0767176B1 Novel glyceroglycophospholipid, antibody there against, and method of detecting mycoplasma |
| 07/21/2004 | EP0635030B1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS |
| 07/21/2004 | CN1514880A Method and compositions for making emamectin |
| 07/21/2004 | CN1514844A Modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicity |
| 07/21/2004 | CN1514733A Modified erythropoietin (EPO) with reduced immunogenicity |
| 07/21/2004 | CN1513997A Method of detecting 5'-methioadenosine phosphorylase defect type mammarian cell |
| 07/21/2004 | CN1513876A P 28 GANK antibody used for liver cancer identification and diagnosis and its preparation method |
| 07/21/2004 | CN1513875A Human source recombination ant keratin gene engineering antibody and its preparation method |
| 07/21/2004 | CN1513874A Human source anti SARS coronavirus gene engineering antibody |
| 07/21/2004 | CN1513558A Anti irritability Specificity Igy and its preparation |
| 07/20/2004 | US6765088 Immunological detection of prions |
| 07/20/2004 | US6765087 Immunoglobulins devoid of light chains |
| 07/20/2004 | US6765085 Polypeptide for use in the amplified propagation of crop plants |
| 07/20/2004 | US6764995 Uses as an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression |
| 07/20/2004 | US6764853 Method for targeted delivery of nucleic acids |
| 07/20/2004 | US6764827 For detection and measurement of serine proteases found in granulocytes |
| 07/20/2004 | US6764689 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 07/20/2004 | US6764687 Live attenuated bacteria for use in a vaccine |
| 07/20/2004 | US6764681 Lymphocyte antibodies |
| 07/20/2004 | US6764680 Administering monoclonal antibodies |
| 07/20/2004 | US6764679 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 07/20/2004 | CA2227548C Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag) |
| 07/20/2004 | CA2103148C Determination of motifs of peptides on mhc molecules |
| 07/20/2004 | CA2096159C Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates |
| 07/15/2004 | WO2004059285A2 Tumor killing/tumor regression using cxcr4 antagonists |
| 07/15/2004 | WO2004059278A2 Methods of screening for anti-inflammatory drugs and use thereof |
| 07/15/2004 | WO2004058986A2 Btl-ii nucleic acids, proteins, and antibodies |
| 07/15/2004 | WO2004058973A1 Fluorescent proteins from copepoda species and methods for using same |
| 07/15/2004 | WO2004058949A2 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 07/15/2004 | WO2004058823A1 Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic strip |
| 07/15/2004 | WO2004058822A2 Generation of immunoglobulin molecules with predetermined specificity |
| 07/15/2004 | WO2004058821A2 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
| 07/15/2004 | WO2004058820A2 Single-domain-effector group and its uses |
| 07/15/2004 | WO2004058799A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 07/15/2004 | WO2004058797A2 Human monoclonal antibodies against interleukin 8 (il-8) |